Meilin Liao

Meilin Liao

UNVERIFIED PROFILE

Are you Meilin Liao?   Register this Author

Register author
Meilin Liao

Meilin Liao

Publications by authors named "Meilin Liao"

Are you Meilin Liao?   Register this Author

33Publications

1178Reads

18Profile Views

Endostar in combination with postoperative adjuvant chemotherapy prolongs the disease free survival of stage IIIA NSCLC patients with high VEGF expression.

Oncotarget 2017 Oct 8;8(45):79703-79711. Epub 2017 Jul 8.

Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668083PMC
October 2017

Genome-wide DNA Methylation Analysis Reveals as a Novel Epigenetic Target for 19 Deletion Lung Adenocarcinoma with Induction Erlotinib Treatment.

Clin Cancer Res 2017 Sep 10;23(17):5003-5014. Epub 2017 May 10.

Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, P.R. China.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-16-2688DOI Listing
September 2017

Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study.

Jpn J Clin Oncol 2015 Jun 7;45(6):569-75. Epub 2015 Apr 7.

Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, PR China

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyv036DOI Listing
June 2015

A multicenter, open-label, randomized phase II controlled study of rh-endostatin (Endostar) in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer.

J Thorac Oncol 2015 Jan;10(1):206-11

*Department of Oncology, Shanghai Lung Cancer Center, Chest Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China; †Department of Thoracic Cancer, Cancer Center, West China Hospital, Sichuan University, Chengdu, China; ‡Department of Medical Oncology, Hunan Provincial Tumor Hospital, Changsha, Hunan, China; §Department of Medical Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, China; ‖The Cancer Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; ¶Department of Medical Oncology, Fujian Provincial Tumor Hospital, Fujian Medical University Educational Hospital, Fuzhou, China; #Department of Respiratory Medicine, The First Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing, China; **Chemotherapy Center of Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China; ††Department of Chemotherapy, Affiliated Tumor Hospital, Guangxi Medical University, Guangxi, China; ‡‡Department of Oncology, Shanghai Pulmonary Hospital, Tongji University, Shanghai, China; §§Cancer Center of the First University Hospital, Jilin University, Changchun, China; ‖‖Department of General, Beijing Chest Hospital, Beijing, China; ¶¶Department of Oncology, Second Xiangya Hospital of Central-South University, Changsha, China; and ##Department of Respiratory Disease, Xiang-ya Hospital, Central Southern University, Hunan, Changsha, China.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153079
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000343DOI Listing
January 2015

Long-term results of a randomized controlled trial evaluating preoperative chemotherapy in resectable non-small cell lung cancer.

Onco Targets Ther 2013 7;6:645-50. Epub 2013 Jun 7.

Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S44503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681405PMC
June 2013

The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.

Lung Cancer 2012 Dec 15;78(3):193-200. Epub 2012 Sep 15.

Shanghai Lung Cancer Center, Shanghai Chest Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, 200030, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2012.08.012DOI Listing
December 2012

[A study on the long-term non-small cell lung cancer survivors in the Expand Access Program of gefitinib in China].

Zhongguo Fei Ai Za Zhi 2012 Jun;15(6):332-9

Department of Respiratory Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, 100730 Beijing, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2012.06.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000305PMC
June 2012

Functional roles of PC-PLC and Cdc20 in the cell cycle, proliferation, and apoptosis.

Cell Biochem Funct 2010 Jun;28(4):249-57

Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital, Shanghai Jiaotong University, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbf.1634DOI Listing
June 2010

Association of the CHRNA3 locus with lung cancer risk and prognosis in Chinese Han population.

J Thorac Oncol 2010 May;5(5):658-66

Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shaghai Jiaotong University, 241 Huaihai West Road, Shanghai 200030, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181d5e447DOI Listing
May 2010

First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009.

Lancet Oncol 2009 Nov;10(11):1102-10

Department of Haematology-Oncology, National University Hospital, and Cancer Science Institute of Singapore, National University of Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70238-4DOI Listing
November 2009

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

J Thorac Oncol 2009 Jun;4(6):702-9

Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181a5269dDOI Listing
June 2009

[Guideline of surgical practice for non-small cell lung cancer based staging].

Zhongguo Fei Ai Za Zhi 2004 Oct;7(5):399-403

Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangzhou, Guangdong 510080, P.R.China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2004.05.06DOI Listing
October 2004

[Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer].

Zhongguo Fei Ai Za Zhi 2004 Oct;7(5):449-51

Department of Respiratory Disease, Shanghai Chest Hospital, Shanghai 200030, P.R.China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2004.05.18DOI Listing
October 2004

[Trend of molecular target therapy of non-small cell lung cancer].

Authors:
Meilin Liao

Zhongguo Fei Ai Za Zhi 2004 Aug;7(4):270-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2004.04.02DOI Listing
August 2004

[Advances in multimodality therapy of lung cancer].

Zhongguo Fei Ai Za Zhi 2003 Dec;6(6):441-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2003.06.07DOI Listing
December 2003

[Practice guidelines in diagnosis and staging of lung cancer].

Zhongguo Fei Ai Za Zhi 2003 Oct;6(5):330-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2003.05.02DOI Listing
October 2003

[The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer].

Zhonghua Jie He He Hu Xi Za Zhi 2002 Dec;25(12):727-31

Department of Pulmonology, Shanghai Chest Hospital, Shanghai 200030, China.

View Article

Download full-text PDF

Source
December 2002

[Decline of dendritic cells in the peripheral blood of patients with non-small cell lung cancer and its relation to vascular endothelial growth factor].

Zhongguo Fei Ai Za Zhi 2002 Aug;5(4):268-71

Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai 200030, P.R.China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2002.04.08DOI Listing
August 2002

[Value of cardiopulmonary risk index in predicting postoperative short-term prognosis in patients with lung cancer].

Zhongguo Fei Ai Za Zhi 2002 Jun;5(3):194-7

Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai 200030, P.R.China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3779/j.issn.1009-3419.2002.03.11DOI Listing
June 2002